Lyon Joseph Douglas

US insider· US
Sign in for alerts
HoldingsTimelineOverlapsAbout
  • ACQUIREDT+7

    Corcept Therapeutics Inc · NASDAQ

    +3,357 sh · $45.5K

    Filed 5 Oct 2026SEC Form 4view source
  • REDUCEDT+7

    Corcept Therapeutics Inc · NASDAQ

    −4,744 sh · $552.9K

    Filed 5 Oct 2026SEC Form 4view source
  • REDUCEDT+7

    Corcept Therapeutics Inc · NASDAQ

    −810 sh · $93.5K

    Filed 5 Oct 2026SEC Form 4view source
  • ACQUIREDT+7

    Corcept Therapeutics Inc · NASDAQ

    +810 sh · $11.0K

    Filed 5 Oct 2026SEC Form 4view source
  • ACQUIREDT+7

    Corcept Therapeutics Inc · NASDAQ

    +5,833 sh · $112.3K

    Filed 5 Oct 2026SEC Form 4view source
  • REDUCEDT+7

    Corcept Therapeutics Inc · NASDAQ

    −4,446 sh · $514.4K

    Filed 5 Oct 2026SEC Form 4view source
  • REDUCEDT+30

    Corcept Therapeutics Inc · NASDAQ

    −2,188 sh · $249.7K

    Filed 16 Sept 2026SEC Form 4view source
  • REDUCEDT+30

    Corcept Therapeutics Inc · NASDAQ

    −7,812 sh · $885.3K

    Filed 16 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Corcept Therapeutics Inc · NASDAQ

    +2,596 sh · $29.5K

    Filed 16 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Corcept Therapeutics Inc · NASDAQ

    +7,404 sh · $100.4K

    Filed 16 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Corcept Therapeutics Inc · NASDAQ

    −72 sh · $8.2K

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Corcept Therapeutics Inc · NASDAQ

    +130 sh · $14.7K

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Corcept Therapeutics Inc · NASDAQ

    +130 sh

    Filed 3 Sept 2026SEC Form 4view source